The expression of STAT3, BCL-XL and MMP-2 proteins in colon adenocarcinomas and their relationship with prognostic factors;Kolon adenokarsinomlari{dotless}nda STAT3, BCL-XL ve MMP-2 proteinlerinin sali{dotless}ni{dotless}mi{dotless}ni{dotless}n tani{dotless}sal deǧeri ve prognostik faktörler ile İlişkisi

Turk Patoloji Dergisi/Turkish Journal of Pathology

Volumn 30, Issue 3, 2014, Pages 178-183

  Artaş, Gökhan ^a   Özercan, H Ibrahim ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Bcl xL protein; Colonic neoplasms; Matrix Metalloproteinase 2; Prognosis; STAT3 protein

Indexed keywords

GELATINASE A; PROTEIN BCL XL; STAT3 PROTEIN; BCL2L1 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN; PROTEIN BCL X; STAT3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR VOLUME; ADENOCARCINOMA; AGED; BIOSYNTHESIS; COLON TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; BCL-X PROTEIN; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; STAT3 TRANSCRIPTION FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84906729230     PISSN: 10185615     EISSN: 13095730     Source Type: Journal    
DOI: 10.5146/tjpath.2014.01269     Document Type: Article

References (36)

1. Kumar R, Abbas A, DeLancey A, Malone E. Pathologic basis of disease. 8th. ed, Philadelphia: Saunders; 2010. 815-26.
2. Hamilton SR, Bosman FT, Boffetta P, Ilyas M, Morreau H, Nakamura SI. Carcinoma of the colon and rectum. Bosman FT, Carneiro F, Hruban RH, Theise ND. editors. Pathology and genetics of tumors of the digestive system. Lyon: IARC Press; 2010. 132-81.
3. Fenoglio-Preiser CM, Noffsinger AE, Stemmermann GN, Lantz PE, Isaacson PG. Epithelial neoplasms of the colon. Gastrointestinal pathology, an atlas and text. 3rd ed. Philadelphia: Lippincott Williams&Wilkins; 2008. 898-1034.
4. Odze R, Goldblum JR. Epithelial neoplasms of large intestine. Redston M. editor. Surgical pathology of the GI tract, liver, biliary tract and pancreas. 2nd ed. Philadelphia: Saunders Elsevier; 2009. 597-637.
5. Liu C, Crawford JM. Gastrointestinal sistem. Göksel S (çeviren). Kumar V, Fausto N, Abbas A. Hastali{dotless}ǧi{dotless}n patolojik temeli. Sav A, Özdamar ŞO. 7inci baski{dotless}. Ankara: Güneş Ti{dotless}p Kitabevleri; 2009. 828-70.
6. Huang S. Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: Clinic implications. Clin Cancer Res. 2007; 13: 1362-6.
7. Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002; 3: 651-62.
8. Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R. Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res. 2002; 62: 6659-66.
9. Smithgall TE, Briggs SD, Schreiner S, Lerner EC, Cheng H, Wilson MB. Control of myeloid differentiation and survival by Stats. Oncogene. 2000; 19: 2612-8.
10. Huang M, Page C, Reynolds RK, Lin J. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol Oncol 2000; 79: 67-73.
11. Xie TX, Huang FJ, Aldape KD, Kang SH, Liu M, Gershenwald JE, Xie K, Sawaya R, Huang S. Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res. 2006; 66: 3188-96.
12. Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G, Thompson CB. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993; 74: 597-608.
13. Tsujimoto Y, Shimizu S. Bcl-2 family: Life-or-death switch. FEBS Lett. 2000; 466: 6-10.
14. Lynch CC, Matrisian LM. Matrix metalloproteinases in tumorhost cell communication. Differentiation. 2002; 70: 561-73.
15. Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffrey RE, Longcroft JM, Rogers L, Stamp GW. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol. 1992; 141: 389-96.
16. Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev. 2004; 23: 101-17.
17. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: A tail of a frog that became a prince. Nat Rev Mol Cell Biol. 2002; 3: 207-14.
18. Woessner JF, Nagase H. Matrix Metalloproteinases and TIMPs. New York: Oxford University Press Inc; 2000. 112-43.
19. Ilgun AS, Yildirim N, Sit M, Oner OZ, Gedik ML, Gonullu D, Koksoy FN. Relationship of lymph node ratio, standart prognostic factors and survival in patients with colorectal cancer. JAREM. 2013; 3: 14-8.
20. Lee SW, Ahn YY, Kim YS, Kang SB, Nam SW, Lee DS, Jeong HY, Kim JM. The Immunohistochemical Expression of STAT3, BclxL, and MMP-2 Proteins in colon adenoma and adenocarcinoma. Gut Liver. 2012; 6: 45-51.
21. Ma XT, Wang S, Ye YJ, Du RY, Cui ZR, Somsouk M. Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma. World J Gastroenterol. 2004; 10: 1569-73.
22. Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Inoue K, Nagayasu T, Sekine I. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol Rep. 2006; 15: 1445-51.
23. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993; 75: 241-51.
24. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science. 2005; 309: 1732-5.
25. Bose P, Klimowicz AC, Kornaga E, Petrillo SK, Matthews TW, Chandarana S, Magliocco AM, Brockton NT, Dort JC. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma. BMC Cancer. 2012; 12: 332-44.
26. Lin HX, Qiu HJ, Zeng F, Rao HL, Yang GF, Kung HF, Zhu XF, Zeng YX, Cai MY, Xie D. Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinoma. PLoS One. 2013; 8: e60516.
27. Korkolopoulou P, Lazaris ACh, Konstantinidou AE, Kavantzas N, Patsouris E, Christodoulou P, Thomas-Tsagli E, Davaris P. Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival. Eur Urol. 2002; 41: 274-83.
28. Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H, Ungefroren H. Bcl-XL protects pancreatic adenocarcinoma cells against CD95-and TRAILreceptor-mediated apoptosis. Oncogene. 2000; 19: 5477-86.
29. Zhou DH, Yang LN, Roder C, Kalthoff H, Trauzold A. TRAILinduced expression of uPA and IL-8 strongly enhanced by overexpression of TRAF2 and Bcl-xL in pancreatic ductal adenocarcinoma cells. Hepatobiliary Pancreat Dis Int. 2013; 12: 94-8.
30. Li JY, Li YY, Jin W, Yang Q, Shao ZM, Tian XS. ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL. J Exp Clin Cancer Res. 2012; 31: 102.
31. Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Seki N, Nakagawa M, Dahiya R. Genistein upregulates tumor suppressor microRNA-574-3p in prostate cancer. PLoS One. 2013; 8: e58929.
32. Li X, Marani M, Mannucci R, Kinsey B, Andriani F, Nicoletti I, Denner L, Marcelli M. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res. 2001; 61: 1699-706.
33. Zhang YL, Pang LQ, Wu Y, Wang XY, Wang CQ, Fan Y. Significance of Bcl-xL in human colon carcinoma. World J Gastroenterol. 2008; 14: 3069-73.
34. Amǎlinei C, Cǎruntu ID, Giuşcǎ SE, Bǎlan RA. Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol. 2010; 51: 215-28.
35. Tomita T, Iwata K. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. Dis Colon Rectum. 1996; 39: 1255-64.
36. Shin JE, Jung SA, Kim SE, Joo YH, Shim KN, Kim TH, Yoo K, Moon IH. Expression of MMP-2, HIF-1 alpha and VEGF in colon adenoma and colon cancer. Korean J Gastroenterol 2007; 50: 9-18.